The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Screening of colorectal cancer (CRC) patients for lynch syndrome (LS) emphasizes the need for public insurance coverage of genetic testing: Results of a national program by the Hellenic Society of Medical Oncology (HeSMO).
 
Zacharenia Saridaki
No Relationships to Disclose
 
Emmanouil S. Saloustros
No Relationships to Disclose
 
Nikolaos Tsoukalas
No Relationships to Disclose
 
Thomas Makatsoris
No Relationships to Disclose
 
Georgios Lypas
No Relationships to Disclose
 
Haralabos Kalofonos
No Relationships to Disclose
 
Athina Christopoulou
No Relationships to Disclose
 
Iliada Bompolaki
No Relationships to Disclose
 
Ioannis Sougklakos
Consulting or Advisory Role - Roche (Inst); SERVIER (Inst)
Speakers' Bureau - Sanofi
Research Funding - Amgen (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Amgen; Merck Serono; Roche; Sanofi; SERVIER; SERVIER
 
Evangelos Voulgaris
No Relationships to Disclose
 
Athanasios Karampeazis
Honoraria - Roche
Travel, Accommodations, Expenses - Astellas Pharma; Galenica; Pfizer
 
Christos Papandreou
No Relationships to Disclose
 
Athanasios Anagnostopoulos
No Relationships to Disclose
 
Eleni P. Galani
No Relationships to Disclose
 
Konstantinos Ballasis
No Relationships to Disclose
 
Flora Zagouri
No Relationships to Disclose
 
Georgios Rizos
No Relationships to Disclose
 
Athanasios Athanasiadis
No Relationships to Disclose
 
Ioannis I. Varthalitis
No Relationships to Disclose
 
Ioannis Boukovinas
Employment - Pierre Fabre (I)
Honoraria - AstraZeneca; Bristol-Myers Squibb; LEO Pharma; Merck; MSD; Novartis; Pfizer; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Genesis Pharma; Ipsen; LEO Pharma; MSD; Novartis; Roche; Sanofi
Research Funding - Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Regeneron; Roche
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD; Pfizer; Roche